OraSure Technologies (OSUR) to Release Earnings on Tuesday

OraSure Technologies (NASDAQ:OSUR) is anticipated to announce its earnings results after the market closes on Tuesday, February 25th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $36.76 million for the quarter. Investors that are interested in registering for the company’s conference call can do so using this link.

OraSure Technologies Trading Up 1.0 %

Shares of OSUR stock opened at $3.93 on Tuesday. The firm’s 50 day moving average is $3.81 and its 200 day moving average is $4.04. The stock has a market capitalization of $293.14 million, a P/E ratio of 26.20 and a beta of 0.05. OraSure Technologies has a 12 month low of $3.52 and a 12 month high of $8.04.

Analyst Upgrades and Downgrades

Separately, StockNews.com downgraded OraSure Technologies from a “buy” rating to a “hold” rating in a research report on Thursday, February 13th.

About OraSure Technologies

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.